Category

2023
  Published Date:2023-02-08 Original Link:https://www.onenessbio.com/en/news_detail200_5.htm Contact Us繁簡EN
Read More
Published Date:2023-01-31 Original Link:https://www.onenessbio.com/en/news_detail199_5.htm No 2 Date of announcement 2023/01/31 Time of announcement 18:19:35 Subject Oneness Board of Directors resolved to convene the Annual Shareholders’ Meeting of 2023. To which item it meets paragraph 17 Date of events 2023/01/31 Statement Date of the board of directors resolution:2023/01/31 General shareholders’ meeting date:2023/04/18 General shareholders’ meeting location:Building...
Read More
Published Date:2023-01-31 Original Link:https://www.onenessbio.com/en/news_detail198_5.htm No 1 Date of announcement 2023/01/31 Time of announcement 18:16:51 Subject Oneness received new drug approval by Singapore HSA on its DFU new drug, FESPIXON. To which item it meets paragraph 10 Date of events 2023/01/31 Statement Product:FESPIXON, a new drug for the treatment of diabetic foot ulcer Mass production date:NA...
Read More
Published Date:2023-01-31 Original Link:https://www.onenessbio.com/en/news_detail197_5.htm Contact Us繁簡EN
Read More
Published Date:2023-01-17 Original Link:https://www.onenessbio.com/en/news_detail196_5.htm No 2 Date of announcement 2023/01/17 Time of announcement 18:28:34 Subject An U.S. patent titled “METHOD FOR PREPARING PLECTRANTHUS AMBOINICUS FRACTION HAVING ANTI-ARTHRITIS ACTIVITY” has been granted. To which item it meets paragraph 53 Date of events 2023/01/17 Statement Date of occurrence of the event:2023/01/17 Company name:ONENESS BIOTECH CO., LTD. Relationship...
Read More
Published Date:2023-01-13 Original Link:https://www.onenessbio.com/en/news_detail195_5.htm No 1 Date of announcement 2023/01/13 Time of announcement 15:16:40 Subject The CEA of Fespixon based on its significant clinical efficacy showed its cost-effectiveness for treating DFUs. The manuscript was published by JAMA Network Open To which item it meets paragraph 53 Date of events 2023/01/13 Statement Date of occurrence of...
Read More
Published Date:2023-01-11 Original Link:https://www.onenessbio.com/en/news_detail194_5.htm No 1 Date of announcement 2023/01/11 Time of announcement 01:54:34 Subject The exploratory trial result of Fespixon in improving postoperative scar cosmesis has been published by a renowned SCI journal, Aesthetic Surgery Journal. To which item it meets paragraph 53 Date of events 2023/01/10 Statement Date of occurrence of the event:2023/01/10...
Read More
Published Date:2023-01-05 Original Link:https://www.onenessbio.com/en/news_detail369_5.htm Contact Us繁簡EN
Read More
Published Date:2023-01-05 Original Link:https://www.onenessbio.com/en/news_detail366_5.htm Contact Us繁簡EN
Read More
1 5 6 7